Geographic Variation of Antidementia and Antipsychotic Medication Use Among US Nursing Home Residents With Dementia.

ABSTRACT:

Background

Several antidementia medications have been approved for symptomatic treatment of cognitive and functional impairment due to Alzheimer disease. Antipsychotics are often prescribed off-label for behavioral symptoms.

Objective

The aim of this study was to describe the basis for regional variation in antidementia and antipsychotic medication use.

Setting

US nursing homes (n=9735), hospital referral regions (HRR; n=289).

Subjects

Long-stay residents with dementia (n=273,004).

Methods

Using 2018 Minimum Data Set 3.0 linked to Medicare data, facility information, and Dartmouth Atlas files, we calculated prevalence of use and separate multilevel logistic models [outcomes: memantine, cholinesterase inhibitor (ChEI), antipsychotic use] estimated adjuste

SUBMITTER: Rataj A 

PROVIDER: S-EPMC12376376 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature